<?xml version="1.0" encoding="UTF-8"?>
<ANNEX xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:fmx="http://opoce" xsi:noNamespaceSchemaLocation="http://formex.publications.europa.eu/schema/formex-05.55-20141201.xd"><BIB.INSTANCE><DOCUMENT.REF FILE="L_2016078EN.01006001.doc.xml"><COLL>L</COLL><NO.OJ>078</NO.OJ><YEAR>2016</YEAR><LG.OJ>EN</LG.OJ><PAGE.FIRST>60</PAGE.FIRST><PAGE.SEQ>1</PAGE.SEQ><VOLUME.REF>01</VOLUME.REF></DOCUMENT.REF><DATE ISO="20160314">20160314</DATE><LG.DOC>EN</LG.DOC><NO.SEQ>0011.0001</NO.SEQ><PAGE.FIRST>70</PAGE.FIRST><PAGE.SEQ>1</PAGE.SEQ><PAGE.LAST>71</PAGE.LAST><PAGE.TOTAL>2</PAGE.TOTAL></BIB.INSTANCE><TITLE><TI><P>ANNEX I</P></TI></TITLE><CONTENTS><GR.SEQ LEVEL="1"><TITLE><TI><P><HT TYPE="BOLD">Conditions for assessing an exemption from the large exposure limit, in accordance with Article 400(2)(c) of Regulation (EU) No 575/2013 and Article 9(3) of this Regulation</HT></P></TI></TITLE><NP><NO.P>1.</NO.P><TXT>This Annex applies in respect of exemptions from the large exposure limit under Article 9(3) of this Regulation. For the purposes of Article 9(3), third countries listed in Annex I to Commission Implementing Decision 2014/908/EU<NOTE NOTE.ID="E0001" NUMBERING="ARAB" TYPE="FOOTNOTE"><P>Commission Implementing Decision 2014/908/EU of <DATE ISO="20141212">12 December 2014</DATE> on the equivalence of the supervisory and regulatory requirements of certain third countries and territories for the purposes of the treatment of exposures according to Regulation (EU) No 575/2013 of the European Parliament and of the Council (<REF.DOC.OJ COLL="L" DATE.PUB="20141216" NO.OJ="359" PAGE.FIRST="155">OJ L 359, 16.12.2014, p. 155</REF.DOC.OJ>).</P></NOTE> are deemed to be equivalent.</TXT></NP><NP><NO.P>2.</NO.P><TXT>Credit institutions must take the following criteria into account when assessing whether an exposure referred to in Article 400(2)(c) of Regulation (EU) No 575/2013 meets the conditions for an exemption from the large exposure limit, in accordance with Article 400(3) of Regulation (EU) No 575/2013.</TXT><P><LIST TYPE="alpha"><ITEM><NP><NO.P>(a)</NO.P><TXT>For the purpose of assessing whether the specific nature of the exposure, the counterparty or the relationship between the credit institution and the counterparty eliminate or reduce the risk of the exposure, as provided for in Article 400(3)(a) of Regulation (EU) No 575/2013, credit institutions must take into account whether:</TXT><P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>the conditions provided for in Article 113(6)(b), (c) and (e) of Regulation (EU) No 575/2013 are met and in particular whether the counterparty is subject to the same risk evaluation, measurement and control procedures as the credit institution and whether the IT systems are integrated or, at least, fully aligned. In addition, they must take into account whether there are any current or anticipated material practical or legal impediments that would hinder the timely repayment of the exposure by the counterparty to the credit institution, other than in the event of a recovery or resolution situation when the restrictions outlined in Directive 2014/59/EU of the European Parliament and of the Council<NOTE NOTE.ID="E0002" NUMBERING="ARAB" TYPE="FOOTNOTE"><P>Directive 2014/59/EU of the European Parliament and of the Council of <DATE ISO="20140515">15 May 2014</DATE> establishing a framework for the recovery and resolution of credit institutions and investment firms and amending Council Directive 82/891/EEC, and Directives 2001/24/EC, 2002/47/EC, 2004/25/EC, 2005/56/EC, 2007/36/EC, 2011/35/EU, 2012/30/EU and 2013/36/EU, and Regulations (EU) No 1093/2010 and (EU) No 648/2012, of the European Parliament and of the Council (<REF.DOC.OJ COLL="L" DATE.PUB="20140612" NO.OJ="173" PAGE.FIRST="190">OJ L 173, 12.6.2014, p. 190</REF.DOC.OJ>).</P></NOTE> are required to be implemented;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>the proposed intragroup exposures are justified by the group's funding structure;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>the process by which a decision is made to approve an exposure to the intragroup counterparty, and the monitoring and review process applicable to such exposures, at individual level and at consolidated level, where relevant, are similar to those that are applied to third party lending;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>the credit institution's risk management procedures, IT system and internal reporting enable it to continuously check and ensure that large exposures to group undertakings are aligned with its risk strategy at legal entity level and at consolidated level, where relevant.</TXT></NP></ITEM></LIST></P></NP></ITEM><ITEM><NP><NO.P>(b)</NO.P><TXT>For the purpose of assessing whether any remaining concentration risk can be addressed by other equally effective means such as the arrangements, processes and mechanisms provided for in Article 81 of Directive 2013/36/EU, as provided for in Article 400(3)(b) of Regulation (EU) No 575/2013, credit institutions must take into account whether:</TXT><P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>the credit institution has robust processes, procedures and controls, at individual level and at consolidated level, where relevant, to ensure that use of the exemption would not result in concentration risk that is outside its risk strategy and against the principles of sound internal liquidity management within the group;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>the credit institution has formally considered the concentration risk arising from intragroup exposures as part of its overall risk assessment framework;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>the credit institution has a risk control framework, at legal entity level and at consolidated level where relevant, that adequately monitors the proposed exposures;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>the concentration risk arising has been or will be clearly identified in the internal capital adequacy assessment process (ICAAP) of the credit institution and will be actively managed. The arrangements, processes and mechanisms to manage the concentration risk will be assessed in the supervisory review and evaluation process;</TXT></NP></ITEM><ITEM><NP><NO.P>(v)</NO.P><TXT>there is evidence that the management of concentration risk is consistent with the group's recovery plan.</TXT></NP></ITEM></LIST></P></NP></ITEM></LIST></P></NP><?PAGE NO="71"?><NP><NO.P>3.</NO.P><TXT>For the purposes of verifying whether the conditions specified in paragraph 1 and 2 are met, the European Central Bank may request credit institutions to submit the following documentation.</TXT><P><LIST TYPE="alpha"><ITEM><NP><NO.P>(a)</NO.P><TXT>A letter signed by the credit institution's legal representative, with approval from the management body, stating that the credit institution complies with all the conditions for an exemption as laid down in Article 400(2)(c) and Article 400(3) of Regulation (EU) No 575/2013.</TXT></NP></ITEM><ITEM><NP><NO.P>(b)</NO.P><TXT>A legal opinion, issued either by an external independent third party or by an internal legal department, and approved by the management body, demonstrating that there are no obstacles that would hinder timely repayment of exposures by a counterparty to the credit institution that arise from either applicable regulations, including fiscal regulations, or binding agreements.</TXT></NP></ITEM><ITEM><NP><NO.P>(c)</NO.P><TXT>A statement signed by the legal representative and approved by the management body stating that:</TXT><P><LIST TYPE="roman"><ITEM><NP><NO.P>(i)</NO.P><TXT>there are no practical impediments that would hinder the timely repayment of exposures by a counterparty to the credit institution;</TXT></NP></ITEM><ITEM><NP><NO.P>(ii)</NO.P><TXT>intragroup exposures are justified by the group's funding structure;</TXT></NP></ITEM><ITEM><NP><NO.P>(iii)</NO.P><TXT>the process by which a decision is made to approve an exposure to an intragroup counterparty and the monitoring and review process applicable to such exposures, at legal entity level and at consolidated level, are similar to those that are applied to third-party lending;</TXT></NP></ITEM><ITEM><NP><NO.P>(iv)</NO.P><TXT>concentration risk arising from intragroup exposures has been considered as part of the credit institution's overall risk assessment framework.</TXT></NP></ITEM></LIST></P></NP></ITEM><ITEM><NP><NO.P>(d)</NO.P><TXT>Documentation signed by the legal representative and approved by the management body attesting that the credit institution's risk evaluation, measurement and control procedures are the same as the counterparty's and that the credit institution's risk management procedures, IT system and internal reporting enable the management body to continuously monitor the level of the large exposure and its compatibility with the credit institution's risk strategy at legal entity level and at consolidated level, where relevant, and with the principles of sound internal liquidity management within the group.</TXT></NP></ITEM><ITEM><NP><NO.P>(e)</NO.P><TXT>Documentation showing that the ICAAP clearly identifies the concentration risk arising from the large intragroup exposures and that this risk is actively managed.</TXT></NP></ITEM><ITEM><NP><NO.P>(f)</NO.P><TXT>Documentation showing that the management of concentration risk is consistent with the group's recovery plan.</TXT></NP></ITEM></LIST></P></NP></GR.SEQ></CONTENTS></ANNEX>